Business & regional news

A minimally invasive approach, the ILLUMISITE™ platform navigates accurately to even the most distant areas of the lung, and can sample multi-directionally for a thorough biopsy. Medtronic...

Clinicians now have added ability to personalize care with the integration of two continuous monitoring solutions from Medtronic plc...

Medtronic presence to include 1 3 data presentations, a LinkedIn Livestream featuring Que Dallara, EVP & President, Medtronic Diabetes, comprehensive exhibit booth with presentations and a product theatre

Built on the market-leading IN.PACT™ Admiral™ DCB technology, the IN.PACT™ 018 DCB is engineered to cross tight lesions and designed for better deliverability^§

3BL Media has named Medtronic to its annual 100 Best Corporate Citizens ranking, recognizing outstanding environmental, social and governance (ESG) transparency and performance among the 1,000...

Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique

Prospective study will evaluate the long-term performance of the closed-loop algorithm and overall patient experience with Medtronic’s next generation, rechargeable spinal cord stimulation device

The Hugo™ RAS system has won a “Medical Device Innovation Award” in the 2022 MedTech Breakthrough Awards program. “After more than 20 years of availability, robotic-assisted surgery only...

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population

Heart Rhythm 2022: Sub-analysis indicates patients with intermittent monitoring may not be optimally managed for secondary stroke prevention

Medtronic, the global leader in medical technology, today announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB)...

Medtronic today announced that it has signed an agreement with Acutus Medical Inc., a manufacturer of arrhythmia management technologies, for exclusive rights to distribute and acquire its...

Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference

Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...

Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...

AccuRhythm AI algorithms shown to reduce false alerts by 84%

ACC.22: Late-breaking data show CoreValve™ and Evolut™ is the only platform to out-perform surgery in valve durability at five years